Patent 7145014 was granted and assigned to Smithkline Beecham Limited on December, 2006 by the United States Patent and Trademark Office.
The invention relates to a process for the preparation of certain quinoline derivatives, in particular, 8-[(4-amino-1-methylbutyl)amino]-2,6-dimethoxy-4-methyl-5-(3-trifluoromethylphenoxy)quinoline succinate.